CDEK
← All drugs Report issue

hemopoietic stem cell

Cell therapyexperimental

Clinical trial activity

74 trials · 74 clinical orgs · 0 marketing orgs

Phase 1
30
Phase 2
48
Phase 3
7
Phase 4
1

Earliest trial started Jun 1, 1997 (NCT00278551)

Timeline

1990s

  1. Jan 1, 1997

    Earliest Phase 1 Sponsor(trial)

2000s

  1. Jan 1, 2002

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2002

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetTissue restoration

    tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • haematopoietic stem cell
  • hematopoetic stem cell
  • hematopoetic stem cells
  • hematopoietic stem cell
  • hematopoietic stem cells
  • hemopoietic stem cell

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02986698Phase 1Jul 1, 2017University of California, San Francisco
NCT02999854Phase 3May 1, 2017Kiadis Pharma, University of Montreal
NCT02665065Phase 3Jun 1, 2016Actinium Pharmaceuticals
NCT02700841Phase 2May 1, 2016Emory University, OncoPep, Inc.
NCT02678143Phase 1Apr 26, 2016Washington University in St. Louis
NCT02652468N/AMar 1, 2016National Cancer Institute (NCI), University of Wisconsin
NCT03080922Phase 1/Phase 2 (Phase 2)Mar 1, 2016People's Liberation Army of China
NCT02676856N/AFeb 1, 2016Southern Medical University
NCT02848183Phase 2Jan 1, 2016Sungkyunkwan University
NCT02176434N/ASep 1, 2015University of Zurich
NCT02487069N/AJun 1, 2015Central South University, Fujian Medical University, Guangzhou Medical University, Hacettepe University, Huazhong University of Science and Technology, People's Liberation Army of China, Shantou University, Southern Medical University, Sun Yat-Sen University
NCT02065596Phase 1/Phase 2 (Phase 2)Apr 1, 2015Case Western Reserve University
NCT02427178Phase 1Mar 1, 2015Columbia University, Cornell University, National Institute of Neurological Disorders and Stroke (NINDS)
NCT02356159Phase 1/Phase 2 (Phase 2)Jan 9, 2015National Cancer Institute (NCI)
NCT03222453N/AJan 1, 2015Guangzhou Medical University, Guangzhou University, Southern Medical University, Sun Yat-Sen University
NCT02167958Phase 1Nov 1, 2014University of Pittsburgh
NCT02161783N/AOct 1, 2014University of Minnesota
NCT02205762Phase 2/Phase 3 (Phase 3)Jul 1, 2014Histiocyte Society, Medical University of Vienna, North American Consortium for Histiocytosis
NCT02084121N/AMar 7, 2014Duke University, University of Louisville
NCT02605460Phase 2Feb 1, 2014Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Showing 20 of 74 trials
Page 1 / 4

Organizations

Research & Development (74)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Northwestern UniversityAcademic/Hospital11741997
University of LouisvilleAcademic/Hospital101022003
National Cancer Institute (NCI)Government8422007
University of MinnesotaAcademic/Hospital7732000
Thomas Jefferson UniversityAcademic/Hospital6612004
Duke UniversityAcademic/Hospital5022005
St. Jude Children's HospitalAcademic/Hospital4332002
Cornell UniversityAcademic/Hospital3222003
Southern Medical UniversityAcademic/Hospital3212015
AmgenFor profit2022000
Columbia UniversityAcademic/Hospital2122008
Guangzhou Medical UniversityAcademic/Hospital2112015
Harvard UniversityAcademic/Hospital2222000
Millennium PharmaceuticalsFor profit2012006
People's Liberation Army of ChinaGovernment2122015
Rutgers UniversityAcademic/Hospital2112010
Sun Yat-Sen UniversityAcademic/Hospital2012015
Talaris TherapeuticsFor profit2012008
University of WashingtonAcademic/Hospital2212009
Actinium PharmaceuticalsFor profit1112016
74 organizations
Page 1 / 4